Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Gliosarcoma × Ipilimumab × Clear all

Phase

Status

Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 26 Carcinoma, Renal Cell 15 Carcinoma, Non-Small-Cell Lung 11 Skin Neoplasms 6 Carcinoma, Hepatocellular 6 Brain Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Colorectal Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Neoplasms 3 Multiple Myeloma 3 Kidney Neoplasms 3 Glioblastoma 3 Carcinoma, Transitional Cell 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Mycosis Fungoides 2 Mesothelioma, Malignant 2 Mesothelioma 2 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2

Interventions

Temozolomide 3 Specimen Handling 2 Radiotherapy 2 peposertib 1 pembrolizumab 1 gosha-jinki-gan 1 efineptakin alfa 1 cabozantinib 1 atezolizumab 1 abexinostat 1 Radiation 1 ONC206 1 Ipilimumab 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07134842 2025-08-21

WinGlio-ipi

University College, London

Phase 1 Recruiting

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡